Marksans Pharma Limited Issues Expansion of Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg & 750mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)
Marksans Pharma Limited, India is voluntarily expanding its earlier initiated recall on June 05, 2020 to include an additional 76 unexpired lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg,& 750mg to the consumer level. Marksans performed N-Nitrosodimethylamine (NDMA) testing of (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 5, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
University of Minnesota receives seed funding for clinical study of metformin to treat, prevent COVID-19
(University of Minnesota Medical School) University of Minnesota Medical School researchers received funding from the Parsemus Foundation to initiate research on the widely-used diabetes medication, metformin, available globally as an inexpensive generic drug for prevention and treatment for COVID-19. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 25, 2020 Category: International Medicine & Public Health Source Type: news
Diabetes Drug Metformin May Protect Aging Brains
Title: Diabetes Drug Metformin May Protect Aging BrainsCategory: Health NewsCreated: 9/23/2020 12:00:00 AMLast Editorial Review: 9/24/2020 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - September 24, 2020 Category: Endocrinology Source Type: news
Diabetes Drug Metformin May Protect Aging Brains
New research suggests that people taking the drug appear to have significantly slower declines in thinking and memory as they age. (Source: WebMD Health)
Source: WebMD Health - September 23, 2020 Category: Consumer Health News Source Type: news
Sun Pharmaceutical Industries, Inc. Issues Voluntary Nationwide Recall of RIOMET ER ™ (Metformin Hydrochloride for Extended-Release Oral Suspension) Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Sun Pharmaceutical Industries, Inc. (SUN PHARMA), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. is voluntarily recalling one lot of RIOMET ER ™ (metformin hydrochloride for extended-release oral suspension), 500 mg per 5 mL to the consumer level. The reason for the recall is due to (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 23, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Metformin May Slow Cognitive Decline in Seniors With T2DM
Cognitive decline slower, dementia risk reduced in seniors with diabetes receiving metformin (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 23, 2020 Category: Psychiatry Tags: Endocrinology, Family Medicine, Geriatrics, Internal Medicine, Neurology, Pharmacy, Psychiatry, Radiology, Journal, Source Type: news
Metformin May Slow Cognitive Decline in Seniors With T2DM
WEDNESDAY, Sept. 23, 2020 -- For older adults with type 2 diabetes, cognitive decline is slower and dementia risk reduced for those receiving metformin, according to a study published online Sept. 23 in Diabetes Care.
Katherine Samaras, M.B.B.S.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 23, 2020 Category: Pharmaceuticals Source Type: news
Diabetes Drug Metformin May Protect the Aging Brain
WEDNESDAY, Sept. 23, 2020 -- A common type 2 diabetes drug called metformin may have an unexpected, but positive, side effect: New research suggests that people taking the drug appear to have significantly slower declines in thinking and memory as... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 23, 2020 Category: General Medicine Source Type: news
Three-drug combo reduces risk for lung cancer by 17%, study finds
Taking aspirin, statins and the drug metformin together reduces the risk for lung cancer by 17%, a study published Thursday by the Journal of Thoracic Oncology found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 17, 2020 Category: Consumer Health News Source Type: news
Three common medications lower risk and mortality for lung cancer
(International Association for the Study of Lung Cancer) Combined use of aspirin, statins, and metformin is associated with decreased lung cancerincidence and mortality, according to a study published in the Journal of Thoracic Oncology (JTO). The JTO is the official journal of the International Association for the Study of Lung Cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 17, 2020 Category: Cancer & Oncology Source Type: news
How to mete out metformin
(Source: ScienceNOW)
Source: ScienceNOW - September 16, 2020 Category: Science Authors: Charneski, C. A. Tags: twis Source Type: news
Common diabetes drug reverses inflammation in the liver
(Salk Institute) The diabetes drug metformin has been prescribed to hundreds of millions of people worldwide as the frontline treatment for type 2 diabetes. Now, researchers at the Salk Institute have shown the importance of specific enzymes in the body for metformin's function. In addition, the new work showed that the same proteins, regulated by metformin, controlled aspects of inflammation in mice, something the drug has not typically been prescribed for. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 9, 2020 Category: International Medicine & Public Health Source Type: news
Rigorous Detection of Nitrosamine Contaminants in Metformin Products: Balancing Product Safety and Product Accessibility
Nitrosamines are a class of chemicals that commonly occur as impurities in water, beverages, and foods (particularly in cured and grilled meats). Although nitrosamines are generally regarded to be carcinogenic, small amounts of exposure are not considered to be harmful. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 4, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
SGLT2 Inhibitors With Metformin Do Not Up Fracture Risk SGLT2 Inhibitors With Metformin Do Not Up Fracture Risk
The combination of SGLT-2 inhibitors and metformin is not associated with an increase in fracture risk among patients with type 2 diabetes, according to a meta-analysis of 25 randomized, controlled trials.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - August 21, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Bayshore Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 750 mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Bayshore Pharmaceuticals, LLC, Short Hills, NJ is voluntarily recalling one (1) lot of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg, 1000 count bottles and one (1) lot of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 count bottles within expiry to the consumer lev (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 20, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
